# Jonathan de Courcy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jonathan-de-courcy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 442 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 8 |
| i10-index | 7 |
| Last Known Institution | Adelphi Group (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5104955568 |
| ORCID iD | 0000-0002-2100-5279 |
| Works | 55 |

## Researcher papers

- [Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes](https://scholariq.org/papers/real-world-evidence-generation-from-patients-their-caregivers-and-physicians/)
- [A burden of illness study for neuropathic pain in Europe](https://scholariq.org/papers/a-burden-of-illness-study-for-neuropathic-pain-in-europe/)
- [Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in real-world practice in six European countries](https://scholariq.org/papers/bone-targeted-agent-treatment-patterns-and-the-impact-of-bone-metastases-on/)
- [Real-world outcomes associated with standard half-life and extended half-life factor replacement products for treatment of haemophilia A and B](https://scholariq.org/papers/real-world-outcomes-associated-with-standard-half-life-and-extended-half-life/)
- [Patient-reported Quality of Life and Treatment Satisfaction in Patients With HR+/HER2– Advanced/Metastatic Breast Cancer](https://scholariq.org/papers/patient-reported-quality-of-life-and-treatment-satisfaction-in-patients-with-hr/)
- [Patient-reported pain severity, pain interference and health status in HR+/HER2− advanced/metastatic breast cancer](https://scholariq.org/papers/patient-reported-pain-severity-pain-interference-and-health-status-in-hr-her2/)
- [Bone-targeted agent treatment patterns and the impact of bone metastases on patients with advanced breast cancer in the United States](https://scholariq.org/papers/bone-targeted-agent-treatment-patterns-and-the-impact-of-bone-metastases-on-2/)
- [The impact of myasthenia gravis severity on work and daily activities](https://scholariq.org/papers/the-impact-of-myasthenia-gravis-severity-on-work-and-daily-activities/)
- [Clinical characteristics and impairment of activities of daily living among patients with myasthenia gravis with differing degrees of muscle weakness: a real-world study of patients in the US and five European countries](https://scholariq.org/papers/clinical-characteristics-and-impairment-of-activities-of-daily-living-among/)
- [Real‐World Multinational Survey of Chronic Inflammatory Demyelinating Polyneuropathy: Disease Characteristics and Therapeutic Landscape](https://scholariq.org/papers/real-world-multinational-survey-of-chronic-inflammatory-demyelinating/)
- [Health-related quality of life and productivity burden for non-professional caregivers of adults with rare diseases: a real-world study](https://scholariq.org/papers/health-related-quality-of-life-and-productivity-burden-for-non-professional/)
- [Health Care Resource Utilization and Productivity Impairment in Adults with Immunoglobulin A Nephropathy: A Real-World, Observational, Global Analysis](https://scholariq.org/papers/health-care-resource-utilization-and-productivity-impairment-in-adults-with/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Myasthenia Gravis and Thymoma](https://scholariq.org/topics/myasthenia-gravis-and-thymoma/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

## Researcher university

- [Adelphi Group (United Kingdom)](https://scholariq.org/institutions/adelphi-group-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.